BioLife Price To Sales Ratio vs Inventory Turnover Analysis

BLFS Stock

USD 24.95 0.51 2.00%

BioLife Solutions financial indicator trend analysis is way more than just evaluating BioLife Solutions prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether BioLife Solutions is a good investment. Please check the relationship between BioLife Solutions Price To Sales Ratio and its Inventory Turnover accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioLife Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

For more information on how to buy BioLife Stock please use our How to Invest in BioLife Solutions guide.

Price To Sales Ratio vs Inventory Turnover

Price To Sales Ratio vs Inventory Turnover Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of BioLife Solutions Price To Sales Ratio account and Inventory Turnover. At this time, the significance of the direction appears to have strong relationship.

The correlation between BioLife Solutions' Price To Sales Ratio and Inventory Turnover is 0.69. Overlapping area represents the amount of variation of Price To Sales Ratio that can explain the historical movement of Inventory Turnover in the same time period over historical financial statements of BioLife Solutions, assuming nothing else is changed. The correlation between historical values of BioLife Solutions' Price To Sales Ratio and Inventory Turnover is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price To Sales Ratio of BioLife Solutions are associated (or correlated) with its Inventory Turnover. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Inventory Turnover has no effect on the direction of Price To Sales Ratio i.e., BioLife Solutions' Price To Sales Ratio and Inventory Turnover go up and down completely randomly.

Correlation Coefficient

0.69

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Price To Sales Ratio

Price to Sales Ratio is figured by comparing BioLife Solutions stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on BioLife Solutions sales, a figure that is much harder to manipulate than other BioLife Solutions multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Inventory Turnover

A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.

Most indicators from BioLife Solutions' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into BioLife Solutions current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioLife Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

For more information on how to buy BioLife Stock please use our How to Invest in BioLife Solutions guide.At this time, BioLife Solutions' Enterprise Value Over EBITDA is comparatively stable compared to the past year. Enterprise Value Multiple is likely to gain to 774.95 in 2025, whereas Tax Provision is likely to drop (39.9 K) in 2025.

	2022	2023	2024	2025 (projected)
Total Operating Expenses	93.7M	117.6M	60.8M	63.8M
Cost Of Revenue	107.9M	96.5M	28.6M	30.0M

Total Operating Expenses Cost Of Revenue

BioLife Solutions fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Common Stock Shares Outstanding	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Non Current Liabilities Total	Inventory	Net Receivables	Short Term Debt	Short Long Term Debt Total	Common Stock Total Equity	Short Term Investments
Total Assets		0.98	0.99	1.0	0.94	-0.44	-0.79	0.81	0.74	0.99	0.21	0.97	0.85	0.95	0.74	0.97	0.95	0.94	0.96	0.84	0.94	0.87	0.67	0.23	0.18	0.52
Other Current Liab	0.98		0.98	0.97	0.98	-0.3	-0.73	0.87	0.61	0.98	0.06	0.92	0.74	0.9	0.79	0.92	0.96	0.98	0.89	0.88	0.95	0.91	0.56	0.23	0.17	0.55
Total Current Liabilities	0.99	0.98		0.98	0.96	-0.31	-0.83	0.83	0.64	0.98	0.11	0.97	0.78	0.94	0.8	0.97	0.98	0.97	0.93	0.88	0.98	0.9	0.67	0.25	0.18	0.62
Total Stockholder Equity	1.0	0.97	0.98		0.93	-0.48	-0.79	0.8	0.76	0.99	0.23	0.97	0.86	0.95	0.73	0.97	0.93	0.93	0.96	0.81	0.94	0.85	0.67	0.22	0.17	0.5
Property Plant And Equipment Net	0.94	0.98	0.96	0.93		-0.23	-0.67	0.92	0.55	0.95	0.11	0.86	0.7	0.85	0.76	0.87	0.96	1.0	0.87	0.91	0.91	0.96	0.45	0.23	0.16	0.66
Net Debt	-0.44	-0.3	-0.31	-0.48	-0.23		0.34	-0.03	-0.91	-0.37	-0.38	-0.43	-0.78	-0.5	-0.17	-0.46	-0.18	-0.19	-0.59	-0.01	-0.27	-0.04	-0.43	-0.03	-0.01	0.2
Retained Earnings	-0.79	-0.73	-0.83	-0.79	-0.67	0.34		-0.42	-0.64	-0.74	0.06	-0.88	-0.77	-0.91	-0.8	-0.92	-0.78	-0.7	-0.85	-0.65	-0.89	-0.6	-0.9	-0.24	-0.16	-0.56
Accounts Payable	0.81	0.87	0.83	0.8	0.92	-0.03	-0.42		0.31	0.85	0.28	0.7	0.48	0.66	0.52	0.68	0.85	0.91	0.67	0.85	0.73	0.96	0.2	0.19	0.11	0.65
Cash	0.74	0.61	0.64	0.76	0.55	-0.91	-0.64	0.31		0.67	0.37	0.74	0.96	0.78	0.44	0.76	0.55	0.52	0.85	0.39	0.6	0.37	0.68	0.12	0.15	0.1
Non Current Assets Total	0.99	0.98	0.98	0.99	0.95	-0.37	-0.74	0.85	0.67		0.19	0.95	0.78	0.91	0.72	0.94	0.95	0.95	0.91	0.85	0.93	0.88	0.62	0.22	0.18	0.5
Non Currrent Assets Other	0.21	0.06	0.11	0.23	0.11	-0.38	0.06	0.28	0.37	0.19		0.17	0.36	0.14	-0.38	0.13	0.08	0.07	0.23	0.05	-0.05	0.18	0.06	0.0	0.04	0.07
Other Assets	0.97	0.92	0.97	0.97	0.86	-0.43	-0.88	0.7	0.74	0.95	0.17		0.86	0.95	0.75	0.99	0.93	0.88	0.95	0.81	0.94	0.79	0.81	0.25	0.21	0.5
Cash And Short Term Investments	0.85	0.74	0.78	0.86	0.7	-0.78	-0.77	0.48	0.96	0.78	0.36	0.86		0.89	0.57	0.88	0.71	0.68	0.95	0.56	0.75	0.57	0.74	0.18	0.17	0.36
Common Stock Shares Outstanding	0.95	0.9	0.94	0.95	0.85	-0.5	-0.91	0.66	0.78	0.91	0.14	0.95	0.89		0.8	0.98	0.87	0.86	0.97	0.72	0.95	0.77	0.77	0.23	0.1	0.56
Other Current Assets	0.74	0.79	0.8	0.73	0.76	-0.17	-0.8	0.52	0.44	0.72	-0.38	0.75	0.57	0.8		0.79	0.78	0.78	0.73	0.68	0.87	0.65	0.62	0.16	0.06	0.53
Other Stockholder Equity	0.97	0.92	0.97	0.97	0.87	-0.46	-0.92	0.68	0.76	0.94	0.13	0.99	0.88	0.98	0.79		0.92	0.88	0.97	0.79	0.96	0.78	0.81	0.25	0.18	0.54
Total Liab	0.95	0.96	0.98	0.93	0.96	-0.18	-0.78	0.85	0.55	0.95	0.08	0.93	0.71	0.87	0.78	0.92		0.97	0.88	0.96	0.95	0.92	0.62	0.23	0.27	0.66
Property Plant And Equipment Gross	0.94	0.98	0.97	0.93	1.0	-0.19	-0.7	0.91	0.52	0.95	0.07	0.88	0.68	0.86	0.78	0.88	0.97		0.86	0.92	0.93	0.96	0.48	0.24	0.16	0.68
Total Current Assets	0.96	0.89	0.93	0.96	0.87	-0.59	-0.85	0.67	0.85	0.91	0.23	0.95	0.95	0.97	0.73	0.97	0.88	0.86		0.75	0.91	0.77	0.74	0.22	0.18	0.54
Non Current Liabilities Total	0.84	0.88	0.88	0.81	0.91	-0.01	-0.65	0.85	0.39	0.85	0.05	0.81	0.56	0.72	0.68	0.79	0.96	0.92	0.75		0.83	0.89	0.5	0.2	0.36	0.65
Inventory	0.94	0.95	0.98	0.94	0.91	-0.27	-0.89	0.73	0.6	0.93	-0.05	0.94	0.75	0.95	0.87	0.96	0.95	0.93	0.91	0.83		0.85	0.71	0.23	0.17	0.63
Net Receivables	0.87	0.91	0.9	0.85	0.96	-0.04	-0.6	0.96	0.37	0.88	0.18	0.79	0.57	0.77	0.65	0.78	0.92	0.96	0.77	0.89	0.85		0.35	0.22	0.12	0.79
Short Term Debt	0.67	0.56	0.67	0.67	0.45	-0.43	-0.9	0.2	0.68	0.62	0.06	0.81	0.74	0.77	0.62	0.81	0.62	0.48	0.74	0.5	0.71	0.35		0.28	0.23	0.27
Short Long Term Debt Total	0.23	0.23	0.25	0.22	0.23	-0.03	-0.24	0.19	0.12	0.22	0.0	0.25	0.18	0.23	0.16	0.25	0.23	0.24	0.22	0.2	0.23	0.22	0.28		-0.1	0.34
Common Stock Total Equity	0.18	0.17	0.18	0.17	0.16	-0.01	-0.16	0.11	0.15	0.18	0.04	0.21	0.17	0.1	0.06	0.18	0.27	0.16	0.18	0.36	0.17	0.12	0.23	-0.1		0.03
Short Term Investments	0.52	0.55	0.62	0.5	0.66	0.2	-0.56	0.65	0.1	0.5	0.07	0.5	0.36	0.56	0.53	0.54	0.66	0.68	0.54	0.65	0.63	0.79	0.27	0.34	0.03

Click cells to compare fundamentals

BioLife Solutions Account Relationship Matchups

BioLife Solutions fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	234.8M	552.6M	450.2M	412.7M	399.5M	419.5M
Other Current Liab	9.1M	23.1M	18.7M	21.0M	12.3M	13.0M
Total Current Liabilities	15.6M	42.7M	44.6M	42.2M	32.7M	34.4M
Total Stockholder Equity	205.2M	480.8M	364.2M	337.7M	348.9M	366.4M
Property Plant And Equipment Net	19.8M	36.8M	39.2M	32.6M	16.8M	17.6M
Net Debt	(79.3M)	(43.0M)	24.3M	5.9M	(65.2M)	(62.0M)
Retained Earnings	(97.4M)	(105.0M)	(246.9M)	(313.3M)	(335.1M)	(318.3M)
Accounts Payable	3.7M	14.9M	15.4M	6.9M	3.6M	2.1M
Cash	90.5M	69.9M	19.4M	27.9M	95.4M	100.2M
Non Current Assets Total	120.1M	426.7M	311.8M	292.1M	250.7M	263.3M
Non Currrent Assets Other	4.7M	9.8M	9.3M	(20.9M)	6.5M	6.8M
Other Assets	50K	120.1M	426.7M	386.2M	444.1M	466.3M
Cash And Short Term Investments	90.5M	69.9M	62.7M	44.2M	104.6M	109.8M
Common Stock Shares Outstanding	27.3M	38.5M	42.5M	43.7M	46.1M	48.4M
Liabilities And Stockholders Equity	234.8M	552.6M	450.2M	412.7M	399.5M	419.5M
Other Current Assets	4.6M	4.4M	6.9M	14.3M	6.0M	6.3M
Other Stockholder Equity	302.6M	585.4M	611.7M	651.3M	683.9M	718.1M
Total Liab	29.6M	71.9M	86.0M	75.1M	50.6M	53.1M
Property Plant And Equipment Gross	19.8M	43.5M	48.4M	42.1M	21.1M	22.1M
Total Current Assets	114.7M	125.9M	138.5M	120.6M	148.8M	156.2M
Non Current Liabilities Total	14.0M	31.9M	41.5M	32.9M	17.8M	18.7M
Inventory	11.6M	28.3M	34.9M	43.5M	29.0M	30.5M
Net Receivables	8.0M	23.2M	33.9M	18.7M	9.2M	9.6M
Short Term Debt	1.7M	3.8M	4.8M	7.6M	12.5M	13.1M
Short Long Term Debt Total	11.2M	26.9M	43.7M	33.8M	30.2M	31.7M
Common Stock	33K	42K	43K	45K	47K	37.1K
Current Deferred Revenue	931K	814K	548K	661K	103K	97.9K
Intangible Assets	31.0M	152.1M	32.1M	21.1M	9.6M	9.1M
Property Plant Equipment	1.3M	5.6M	24.5M	46.6M	53.6M	56.3M
Other Liab	41.1M	14.0M	31.9M	2.6M	3.0M	2.8M
Net Tangible Assets	(12.2M)	205.2M	480.8M	364.2M	418.8M	439.8M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for BioLife Stock Analysis

When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC